In this episode, Ellen Csepe introduces transcranial magnetic stimulation (TMS), a novel treatment for depression that has been FDA approved since 2008. She discusses its mechanism, effectiveness, particularly for seniors, and compares it to traditional antidepressants, highlighting its lower side effects. Real patient experiences illustrate the potential of TMS in managing depression, especially for those resistant to medication. The conversation concludes with a call to consider TMS as a viable treatment option for patients struggling with depression.
Want to make sure you stay up to date in all things Geriatrics in less than 3 minutes every other week? Join thousands of others in our free MMOA Digest Email list - https://institute-of-clinical-excellence.kit.com/a3837f54b7